Stock AUPH AURINIA PHARMACEUTICALS INC.
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart Aurinia Pharmaceuticals Inc.

Equities

AUPH

CA05156V1022

Market Closed - Nasdaq
Other stock markets
 02:00:01 04/05/2024 am IST 		5-day change 1st Jan Change
5.1 USD -1.35% Intraday chart for Aurinia Pharmaceuticals Inc. +3.87% -43.27%
02/05 Transcript : Aurinia Pharmaceuticals Inc., Q1 2024 Earnings Call, May 02, 2024
02/05 Earnings Flash (AUPH) AURINIA PHARMACEUTICALS Posts Q1 Revenue $50.3M, vs. Street Est of $47.1M MT
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Bio Therapeutic Drugs

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
AURINIA PHARMACEUTICALS INC. Stock Aurinia Pharmaceuticals Inc.
 728M
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
 105B
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
 104B
ARGENX SE Stock argenx SE
 22.94B -
BIONTECH SE Stock BioNTech SE
 22.34B -
GENMAB A/S Stock Genmab A/S
 19.25B
  1. Stock Market
  2. Equities
  3. AUPH Stock
  4. Charts Aurinia Pharmaceuticals Inc.
  5. Sector Chart
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW